A preview of selected articles
- PMID: 34859967
- PMCID: PMC8641075
- DOI: 10.1002/sct3.13039
A preview of selected articles
References
-
- Wester T, Jørgensen JJ, Stranden E, et al. Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study. Scand J Surg. 2008;97:56‐62. - PubMed
-
- Das AK, Abdullah BJJB, Dhillon SS, Vijanari A, Anoop CH, Gupta PK. Intra‐arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase i study. World J Surg. 2013;37:915‐922. - PubMed
-
- Ulivi V, Tasso R, Cancedda R, Descalzi F. Mesenchymal stem cell paracrine activity is modulated by platelet lysate: induction of an inflammatory response and secretion of factors maintaining macrophages in a proinflammatory phenotype. Stem Cells Dev. 2014;23:1858‐1869. - PubMed
-
- Ratajczak MZ, Kucia M, Jadczyk T, et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell‐secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia. 2012;26:1166‐1173. - PubMed